27 Results for "

VIP peptide

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "VIP peptide" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P1023
CAS No.: 69698-54-0
Target:  

GCGR

Research Areas:  

Metabolic Disease

VIP(6-28)(human, rat, porcine, bovine) is an effective antagonist of the actions of exogenous vasoactive intestinal peptide (VIP) on cAMP.
1
1 Cited Publications
Cat. No.: HY-P1159A
[D-p-Cl-Phe6,Leu17]-VIP TFA is a competitive and selective antagonist of vasoactive intestinal peptide (VIP) receptor, with the IC50 of 125.8 nM. [D-p-Cl-Phe6,Leu17]-VIP TFA has no activity on glucagon, secretin or GRF receptors .
1
1 Cited Publications
Cat. No.: HY-P71061
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Vasoactive intestinal peptide; VIP; Intestinal peptide PHV-42; peptide histidine methioninamide 27; Vasoactive intestinal polypeptide
Species:  
Source:  
Cat. No.: HY-P11288A
Research Areas:  

Cancer

ANT308 TFA is a vasoactive intestinal polypeptide (VIP receptor) antagonist. ANT308 TFA significantly enhances the activation and proliferation of T cells. ANT308 TFA inhibits the migration and metastasis, induces apoptosis of melanoma tumor cells by inhibiting VIP-VPAC2 signaling and reducing the expression of MCAM and N-cadherin. ANT308 TFA can be used for the study of acute myeloid leukemia (AML) and uveal melanoma (UVM) .
Cat. No.: HY-P11288
CAS No.: 2871680-36-1
Research Areas:  

Cancer

ANT308 is a vasoactive intestinal polypeptide (VIP receptor) antagonist. ANT308 significantly enhances the activation and proliferation of T cells. ANT308 inhibits the migration and metastasis, induces apoptosis of melanoma tumor cells by inhibiting VIP-VPAC2 signaling and reducing the expression of MCAM and N-cadherin. ANT308 can be used for the studies of acute myeloid leukemia (AML) and uveal melanoma (UVM) .
Cat. No.: HY-P4776
CAS No.: 202463-00-1
Target:  

PACAP Receptor

Research Areas:  

Metabolic Disease

Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), a vasoactive intestinal peptide (VIP), is a VIP1 antagonist .
Cat. No.: HY-P4127A
M65 TFA is a deleted peptide of maxadilan (61 a.a.) with deletion of the residues between positions 24 and 42 and is a specific antagonist of PACAP type 1 receptor that inhibits ANP secretion and can be used for relevant researches .
Cat. No.: HY-P1015
CAS No.: 96886-24-7
Synonyms: Vasoactive Intestinal peptide, guinea pig
Target:  

PACAP Receptor

VIP Guinea pig (Vasoactive intestinal peptide), a trophic and mitogenic factor, stimulates growth in whole cultured embryos. VIP Guinea pig functions as a simple gastrointestinal hormone and suggest a possible neurotransmitter function .
Cat. No.: HY-P1159
CAS No.: 102805-45-8
[D-p-Cl-Phe6,Leu17]-VIP is a competitive and selective antagonist of vasoactive intestinal peptide (VIP) receptor, with the IC50 of 125.8 nM. [D-p-Cl-Phe6,Leu17]-VIP has no activity on glucagon, secretin or GRF receptors .
Cat. No.: HY-P4127
CAS No.: 1872440-65-7
Target:  

Peptides

Research Areas:  

Neurological Disease

M65 is a deleted peptide of maxadilan (61 a.a.) with deletion of the residues between positions 24 and 42 and is a specific antagonist of PACAP type 1 receptor that inhibits ANP secretion and can be used for relevant researches .
Cat. No.: HY-P4015
CAS No.: 120928-03-2
Target:  

HIV

VIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor .
Cat. No.: HY-P10768A
Target:  

PACAP Receptor

Research Areas:  

Inflammation/Immunology

Ro 25-1553 TFA is a 31 amino acid vasoactive intestinal peptide (VIP) analog, that acts as an agonist for VIP2 receptor (VPAC2 receptor). Ro 25-1553 TFA exhibits a bronchodilator effect in nerve-induced or Carbachol (HY-B1208)-induced tracheal smooth muscle contraction in guinea pig model .
Cat. No.: HY-P3117
CAS No.: 136134-68-4
Synonyms: Pituitary adenylate cyclase-activating peptide (6-27)
Target:  

Adenylate Cyclase

Research Areas:  

Neurological Disease

PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases .
Cat. No.: HY-P1767
CAS No.: 111366-38-2
Target:  

PACAP Receptor

Research Areas:  

Cardiovascular Disease

Prepro VIP (81-122), human is a prepro-vasoactive intestinal polypeptide (VIP) derived peptide, corresponding to residues 81-122. Peptide histidine valine 42 (PHV-42) has been designated to correspond exactly to Prepro VIP (81-122), which reduces both the force and frequency of spontaneous contractions of isolated rat uterus .
Cat. No.: HY-P3050
CAS No.: 93585-83-2
Target:  

GCGR

Research Areas:  

Cardiovascular Disease

Helospectin II is a neuropeptide of the vasoactive intestinal peptide (VIP) family. Helospectin II has vasodilatory and antihypertensive activities, and decreases blood pressure. Helospectin II is originally isolated from the salivary gland venom of the lizard Heloderma suspectum .
Cat. No.: HY-P2702
CAS No.: 89468-62-2
Target:  

Adenylate Cyclase

Research Areas:  

Others

Helodormin is a VIP-secretin-like peptide isolated from the venom of the Mexican monster lizard (Heloderma suspectum). Helodormin affects a variety of cellular functions by modulating intracellular signaling through activation of adenylate cyclase. Helodormin can be used to study the evolution and function of the secretin and VIP peptide families .
Cat. No.: HY-P1015A
Synonyms: Vasoactive Intestinal peptide, guinea pig TFA
Target:  

PACAP Receptor

VIP Guinea pig TFA (Vasoactive intestinal peptide), a trophic and mitogenic factor, stimulates growth in whole cultured embryos. VIP Guinea pig functions as a simple gastrointestinal hormone and suggest a possible neurotransmitter function .
Cat. No.: HY-P0211
CAS No.: 93965-89-0
Target:  

GCGR

Research Areas:  

Cardiovascular Disease

[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist .
Cat. No.: HY-172681
DSPE-PEG2000-VIP is a PEG compound which composed of DSPE and a vasoactive intestinal peptide (VIP). DSPE-PEG2000-VIP can be used for drug delivery .
Cat. No.: HY-172681A
DSPE-PEG3400-VIP is a PEG compound which composed of DSPE and a vasoactive intestinal peptide (VIP). DSPE-PEG3400-VIP can be used for drug delivery .